Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2

Introduction: The current coronavirus disease- 2019 (COVID-19) pandemic has caused a sudden increase in pneumonia cases, with a case-fatality rate of 10.9% in Mexico. Two inpatient groups have been defined, with different clinical evolution: cases of severe pneumonia and those with life-threatening...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Jacobo, Fernando, Villela, Luis Villela, Velásquez-Vega, Edgar, Hernández, Jesús, Otañez, Melani, Arellano-Mendoza, Mónica, Sosa-Camas, Rosa, Manríquez-Bonillas, Víctor, Bejar-Cornejo, Rubén, Pérez, Fausto, Chávez-Ochoa, Joanna, Ramos-Vadillo, Bernardo, Limón-Palafox, Mabel, Jacobo-López, Karen, Vázquez Hernández, Alondra, Rosales Del Real, Ofelia, Mondragón-Posadas, Lidia, Pérez De la O, Alma, Rodríguez-Morales, Pablo, Millán Cureño, Ma. Luisa, Gómez Meza, Martha, Padilla-Ibarra, Cecilia, Soto-Gaxiola, Alan, Melgoza-Gonzáles, Edgar, Hinojosa-Trujillo, Diana, Reyes-Jiménez, Emilio, Serrato-Félix, Marcos, Martínez Arredondo, Hilario, Lehmann Mendoza, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330259/
http://dx.doi.org/10.1182/blood-2020-140631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330259/
http://dx.doi.org/10.1182/blood-2020-140631

Ejemplares similares